To test this hypothesis, we utilized a well-known immune cell abundance score in various cancer types, called TIMER score (27, 39), which was pre-calculated and made available for six immune cell types (B cell, macrophage, dendritic cell, neutrophil, CD4+ T cell, and CD8+ T cell) for TCGA data (see Materials and Methods). This evidence concerns the gene CD4 and cancer.